ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

Bibliographische Detailangaben
Hauptverfasser:	YiHong, S, Bethel, M, Holman, R, Sourij, H, Harrison, P, Tucker, L, Kennedy, I, White, S, Hill, L, Oulhaj, A, Coleman, R, Hu, D
Format:	Journal article
Veröffentlicht:	2013

Ähnliche Einträge

Randomized controlled trial comparing impact on platelet reactivity of twice‐daily with once‐daily aspirin in people with type 2 diabetes
von: Bethel, M, et al.
Veröffentlicht: (2016)

Twice-Daily versus Once-Daily Pramipexole Extended Release Dosage Regimens in Parkinson’s Disease
von: Ji Young Yun, et al.
Veröffentlicht: (2017-01-01)

SIMPLE AND RATIONAL TWICE-DAILY INSULIN REGIME
von: Turner, R, et al.
Veröffentlicht: (1978)

Comparison of Once- with Twice-Daily Dosing of Fluticasone Propionate in Mild and Moderate Asthma
von: Louis-Philippe Boulet, et al.
Veröffentlicht: (2000-01-01)

Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response
von: Moritz Anft, et al.
Veröffentlicht: (2024-09-01)

Effects of Late Conversion from Twice-Daily to Once-Daily Slow Release Tacrolimus on the Insulin Resistance Indexes in Kidney Transplant Patients
von: Valeria Cademartori, et al.
Veröffentlicht: (2021-02-01)

Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial
von: Musiime, V, et al.
Veröffentlicht: (2016)

A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease
von: Hongying Zhang, et al.
Veröffentlicht: (2017-01-01)

Efficacy and safety of a switch from twice-daily tacrolimus to once-daily generic tacrolimus in stable liver transplant patients
von: Jong Man Kim, et al.
Veröffentlicht: (2021-09-01)

Once-daily versus twice-daily enoxaparin for the initial treatment of acute deep venous thrombosis: a case–control study
von: Mohamad T Yusuf, et al.
Veröffentlicht: (2019-01-01)

A Phase I Randomized Trial of Once‐Daily Versus Twice‐Daily Recombinant Human Parathyroid Hormone (1‐84) for Hypoparathyroidism
von: Steven W. Ing, et al.
Veröffentlicht: (2023-07-01)

Retrospective Comparison of the Effectiveness and Safety of Ceftriaxone 1 g Twice Daily versus 2 g Once Daily for Treatment of Aspiration Pneumonia
von: Hideo Kato, et al.
Veröffentlicht: (2022-07-01)

Characteristics of patients needing basal insulin to be given twice-daily or a second insulin formulation during the first year of the 4-T Trial
von: Levy, J, et al.
Veröffentlicht: (2008)

Efficacy and safety of once daily oral administration of sodium‐glucose cotransporter‐2 inhibitor velagliflozin compared with twice daily insulin injection in diabetic cats
von: Stijn J. M. Niessen, et al.
Veröffentlicht: (2024-07-01)

An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial.
von: Connolly, M, et al.
Veröffentlicht: (2009)

LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
von: Jassada Buaboonnam, et al.
Veröffentlicht: (2021-10-01)

Omeprazole Once or Twice Daily with Clarithromycin and Metronidazole for Helicobacter pylori Eradicaiton in a Canadian Community Practice
von: Naoki Chiba, et al.
Veröffentlicht: (2000-01-01)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
von: Ashley, E, et al.
Veröffentlicht: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
von: Ashley, E, et al.
Veröffentlicht: (2007)

Once-Daily Dosing of Aminoglycosides
von: William A Craig
Veröffentlicht: (1994-01-01)

Insulin degludec does not compromise efficacy or safety when given in a flexible once-daily dosing regimen compared to insulin glargine once daily at the same time each day in type 2 diabetes
von: Atkin, S, et al.
Veröffentlicht: (2011)

Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
von: Musiime, V, et al.
Veröffentlicht: (2010)

A simple and rational twice daily insulin regime. Distinction between basal and meal insulin requirements.
von: Phillips, M, et al.
Veröffentlicht: (1979)

Measure twice, cut once /
von: 319488 Tolpin, Jim
Veröffentlicht: (1996)

Twice Daily Prazosin and Valproic Acid in the Treatment of Flashbacks in PTSD
von: Kristy A. Fisher, et al.
Veröffentlicht: (2022-01-01)

Plasma pharmacokinetics of once- versus twice-daily lamivudine and abacavir: simplification of combination treatment in HIV-1-infected children (PENTA-13).
von: Bergshoeff, A, et al.
Veröffentlicht: (2005)

Effect of switching from twice-daily basal insulin to once-daily insulin glargine 300 U/mL (Gla-300) in Brazilian people with type 1 diabetes
von: Patricia Medici Dualib, et al.
Veröffentlicht: (2024-07-01)

Switching from Twice-Daily Basal Insulin Injections to Once-Daily Insulin Degludec Injection for Basal-Bolus Insulin Regimen in Japanese Patients with Type 1 Diabetes: A Pilot Study
von: Yuka Tosaka, et al.
Veröffentlicht: (2015-01-01)

Extended Efficacy of Once-Daily Atomoxetine in ADHD
von: J Gordon Millichap
Veröffentlicht: (2004-07-01)

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES
von: Constantine Tam, et al.
Veröffentlicht: (2023-08-01)

Randomised trial of prophylactic daily aspirin in British male doctors.
von: Peto, R, et al.
Veröffentlicht: (1988)

Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients
von: Max M. Maurer, et al.
Veröffentlicht: (2022-01-01)

TWICE-DAILY SUBCUTANEOUS HUMAN PROINSULIN PROVIDES A SATISFACTORY BASAL INSULIN SUPPLEMENT IN TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
von: Holman, R, et al.
Veröffentlicht: (1987)

A randomised, controlled trial of once daily and multi-dose daily gentamicin in young Kenyan infants.
von: English, M, et al.
Veröffentlicht: (2004)

Bimodal Solutions or Twice-Daily Icodextrin to Enhance Ultrafiltration in Peritoneal Dialysis Patients
von: Periklis Dousdampanis, et al.
Veröffentlicht: (2013-01-01)

The Mayo Clinic experience: Once daily dosing of isotretinoin for acne
von: Hasina Maredia, MD, et al.
Veröffentlicht: (2024-12-01)

Daily low‐dose aspirin and blood pressure in community‐dwelling older adults
von: Michael E. Ernst, et al.
Veröffentlicht: (2024-10-01)

Randomised trial of prophylactic daily aspirin in British male doctors.
von: Weber, E
Veröffentlicht: (1988)

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily
von: Timothy P. Hughes, et al.
Veröffentlicht: (2014-07-01)

Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillation
von: Yang-Qi Pan, et al.
Veröffentlicht: (2024-02-01)